Seres Therapeutics, Inc.

MCRB

$5.69

+0.89%

2026-09-04 13:04:20 EDT+$0.05

Salud

Biotecnología

NASDAQ

Negociación activa

Seres Therapeutics, Inc. es una empresa pionera en terapias para el microbioma dedicada a la ingeniería de consorcios bacterianos que modulan células ...

Ejecutivos C-Level

(0)

El equipo C-Level forma un liderazgo cohesionado que impulsa la estrategia financiera y la innovación de la empresa.

Miembros clave del equipo

No hay ejecutivos para este nivel

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Thomas J. DesRosier	Executive VP, Chief Legal Officer & Secretary	USD 689,733		1955	Active
Marella Thorell	Executive VP, CFO & Treasurer	USD 667,106		1967	Active
Matthew R. Henn	President & Chief Scientific Officer	USD 492,375	—	1975	Active
Chris McChalicher	Executive Vice President & Chief Technology Officer	USD 142,708		—	Active
Richard N. Kender	Interim CEO & Executive Chair	USD 72,500		1956	Active
Dennis Walling	Senior Vice President of Clinical Development & Head of Clinical Research	—	—	—	Active
Ann Kurowski	Senior Vice President of Regulatory Affairs	—		—	Active
Kelly Brady	Executive VP & COO	—		1984	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-27	2025	Eric D. Shaff	Former Former President President and Chief Chief Executive Officer	Founder / CEO	$408.33K	$0	$0	$1.34M	$0	$28.35K	$1.78M
2026-04-27	2025	Thomas J. DesRosier	Former Former Co-President and Co-Chief Executive Officer and current Executive Vice Vice President President and Chief Chief Legal Officer	Founder / CEO	$512.90K	$166.67K	$0	$446.29K	$0	$10.17K	$1.14M
2026-04-27	2025	Marella Thorell	Former Former Co-President and Co-Chief Executive Officer and current Executive Vice Vice President President and Chief Chief Financial Officer	Founder / CEO	$494.40K	$166.67K	$0	$446.29K	$0	$6.04K	$1.11M
2026-04-27	2025	Teresa L. Young, Ph.D.	Former Former Executive Vice Vice President President and Chief Chief Commercial and Strategy Officer	C-Level	$489.30K	$0	$75.68K	$446.29K	$0	$10.19K	$1.02M
2026-04-27	2025	Matthew Henn, Ph.D.	President President and Chief Chief Scientific Officer	C-Level	$489.30K	$0	$75.68K	$446.29K	$0	$3.08K	$1.01M
2026-04-27	2024	Eric D. Shaff	Former Former President President and Chief Chief Executive Officer	Founder / CEO	$685.00K	$0	$116.88K	$1.46M	$411.00K	$9.30K	$2.68M
2026-04-27	2024	Thomas J. DesRosier	Former Former Co-President and Co-Chief Executive Officer and current Executive Vice Vice President President and Chief Chief Legal Officer	Founder / CEO	$498.00K	$0	$39.19K	$502.18K	$199.20K	$9.94K	$1.25M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain de MCRB

RELATIONS

Upstream

Bacthera AGRecipharm AB (publ)STO:RECI BLonza Group AGSWX:LONNNovonesis A/S (formerly Chr. Hansen Holding A/S)CPSE:NSIS BFlagship Pioneering

Downstream

Nestlé Health Science (a division of Nestlé S.A.)SIX:NESN

Proxies

Lonza Group AGSWX:LONNRecipharm AB (publ)STO:RECI BNovonesis A/SCPSE:NSIS BNestlé S.A.SIX:NESN

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal